Page 3 - Nasdaq Bmea News Today

Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report)’s stock price traded down 4% during trading on Tuesday . The company traded as low as $20.80 and last traded at $20.81. 84,439 shares traded hands during mid-day trading, a decline of 89% from the average session volume of 759,073 shares. The stock had previously closed at […]

Biomea Fusion (NASDAQ:BMEA – Free Report) had its price target upped by HC Wainwright from $37.00 to $50.00 in a research report sent to investors on Monday morning, The Fly reports. Several other equities analysts have also recently commented on the company. Keefe, Bruyette & Woods reiterated a buy rating and set a $22.00 target […]

Biomea Fusion (NASDAQ:BMEA – Free Report) had its target price boosted by HC Wainwright from $37.00 to $50.00 in a research report released on Monday, The Fly reports. Several other brokerages have also commented on BMEA. Keefe, Bruyette & Woods restated a buy rating and set a $22.00 target price on shares of Biomea Fusion […]

Biomea Fusion (NASDAQ:BMEA – Get Rating) had its target price lifted by investment analysts at Piper Sandler from $40.00 to $45.00 in a research report issued on Monday, The Fly reports. Piper Sandler’s price target points to a potential upside of 105.95% from the company’s current price. Several other analysts have also recently weighed in […]

Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) traded up 5.8% during trading on Tuesday . The company traded as high as $33.40 and last traded at $33.26. 227,891 shares changed hands during trading, a decline of 63% from the average session volume of 612,261 shares. The stock had previously closed at $31.43. Analysts Set New […]

Shares of Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) have been assigned an average recommendation of “Buy” from the seven brokerages that are currently covering the stock, Marketbeat reports. Six research analysts have rated the stock with a buy rating. The average 12-month price objective among brokerages that have issued a report on the stock […]

Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) major shareholder A2a Pharmaceuticals, Inc. sold 25,000 shares of the stock in a transaction on Friday, May 12th. The shares were sold at an average price of $33.84, for a total transaction of $846,000.00. Following the completion of the transaction, the insider now owns 3,625,000 shares of the […]

Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) was the target of a large increase in short interest in the month of April. As of April 30th, there was short interest totalling 6,080,000 shares, an increase of 28.5% from the April 15th total of 4,730,000 shares. Based on an average daily trading volume, of 866,700 shares, […]

Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) was the recipient of a large increase in short interest during the month of April. As of April 30th, there was short interest totalling 6,080,000 shares, an increase of 28.5% from the April 15th total of 4,730,000 shares. Approximately 20.6% of the shares of the stock are short […]

Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating)’s share price gapped up before the market opened on Friday . The stock had previously closed at $32.10, but opened at $33.40. Biomea Fusion shares last traded at $33.23, with a volume of 20,780 shares. Wall Street Analysts Forecast Growth BMEA has been the subject of a number […]